SCHEMBL4719956

SCHEMBL4719956

CCCOc1s[c]nc1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SOAT1 P35610 1/20 0.38
GAA P10253 2/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
TSHR P16473 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 3/20 0.35
ADORA3 P0DMS8 2/20 0.35
KDM4E B2RXH2 1/20 0.34
ATP4A P20648 3/20 0.34
ATP4B P51164 3/20 0.34
AKT1 P31749 1/20 0.34
AKT2 P31751 1/20 0.34
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4724668 0.92 SOAT1 (0.43) SOAT1MAPTNPSR1ALDH1A1ATP4A
SCHEMBL4720883 0.87 TTK (0.40) MAPTLMNAALDH1A1ADORA3KDM4E
SCHEMBL4724445 0.79 CNR1 (0.37) GAAMAPTLMNATSHRALDH1A1
SCHEMBL468159 0.78 ALDH1A1 (0.41) GAAMAPTLMNATSHRNPSR1
SCHEMBL4719954 0.74 ALDH1A1 (0.35) GAAMAPTLMNAALDH1A1KDM4E
SCHEMBL4765519 0.72 HTR1B (0.39) GAALMNAALDH1A1
SCHEMBL2301856 0.70 ALDH1A1 (0.50) MAPTTSHRNPSR1ALDH1A1KDM4E
SCHEMBL468074 0.70 DYRK1A (0.34)
SCHEMBL4724094 0.70 ALDH1A1 (0.34) SOAT1GAAMAPTLMNAALDH1A1
SCHEMBL4724587 0.70 MAPT (0.37) SOAT1GAAMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC. 2008-07-24 US disclosed
EP-1874780-A1 4-PIPERAZINYLTHIENO[2,3-D]PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS Pharmacia & Upjohn Company LLC (US) 2008-01-09 EP disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176857-A1 4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors TBXA2R, P2RY4, PF4 SOAT1 3558/4885GAA 3876/4885MAPT 4361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.